Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Mesa Laboratories (MLAB) Stock Price & Analysis

92 Followers

MLAB Stock Chart & Stats

$128.25$8.95(7.50%)
At close: 4:00 PM EST
$100$120$140Aug 10Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2
Day’s Range
$119.47 - $128.60
52-Week Range
$69.51 - $144.35
Previous Close
$119.30
Volume
N/A
Average Volume (3M)
97.47K
Market Cap
$717.67M
Enterprise Value
$703.77M
Total Cash (Recent Filing)
$22.31M
Total Debt (Recent Filing)
$88.63M
Price to Earnings (P/E)
108.3
Beta
1.02
Next Earnings
Feb 08, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
Nov 30, 2026
Dividend Yield
0.50%

Bulls Say, Bears Say

Bulls Say

Recurring Compliance-driven Demand

Mesa serves regulated customers that must repeatedly verify process performance and measurement accuracy. This creates recurring demand for consumables, calibration services, replacements, and upgrades, giving the business a durable revenue foundation beyond one-time equipment sales.

Strong Cash Generation

High operating and free cash flow demonstrate strong conversion of revenue into internally generated funds. This supports reinvestment, debt reduction, and resilience across the company’s regulated end markets, while reducing reliance on external financing for ongoing strategic initiatives.

Sterilization Franchise Growth

The sterilization and disinfection control franchise is expanding rapidly and reached its highest trailing-twelve-month revenue in company history. Its growth, supported by continued customer demand, strengthens Mesa’s position in a quality-critical business with recurring validation requirements.

Bears Say

Clinical Genomics Revenue Reset

Clinical genomics has experienced multiyear revenue declines and is now being managed for profitability rather than scale. The planned reset should narrow exposure to weaker business, but lower revenue and a partially fixed-cost base can constrain growth and pressure margins during the transition.

Sterilization Product Reliability Issue

An unresolved reliability problem in a key sterilization product line can hinder customer confidence, delay shipments, and limit the franchise’s ability to fully convert demand into revenue. Until corrected, it remains an execution risk in one of Mesa’s most important growth businesses.

Restructuring And Reinvestment Costs

The restructuring is intended to improve efficiency, but charges and cash outlays will weigh on near-term results. Reinvestment begins ahead of the savings, while full benefits are not expected until fiscal 2028, creating a period of execution risk and margin pressure.

Mesa Laboratories News

MLAB FAQ

What was Mesa Laboratories’s price range in the past 12 months?
Mesa Laboratories lowest stock price was $69.51 and its highest was $144.35 in the past 12 months.
What is Mesa Laboratories’s market cap?
Mesa Laboratories’s market cap is $717.67M.
When is Mesa Laboratories’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Mesa Laboratories’s earnings last quarter?
Mesa Laboratories released its earnings results on Nov 09, 2026. The company reported $0.75 earnings per share for the quarter, missing the consensus estimate of $2.29 by -$1.54.
Is Mesa Laboratories overvalued?
According to Wall Street analysts Mesa Laboratories’s price is currently Undervalued.
Does Mesa Laboratories pay dividends?
Mesa Laboratories pays a Quarterly dividend of $0.16 which represents an annual dividend yield of 0.5%. See more information on Mesa Laboratories dividends here
What is Mesa Laboratories’s EPS estimate?
Mesa Laboratories’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mesa Laboratories have?
Mesa Laboratories has 5,595,869 shares outstanding.
What happened to Mesa Laboratories’s price movement after its last earnings report?
Mesa Laboratories reported an EPS of $0.75 in its last earnings report, missing expectations of $2.29. Following the earnings report the stock price went up 9.457%.
Which hedge fund is a major shareholder of Mesa Laboratories?
Hedge funds hold Mesa Laboratories shares: the largest hedge-fund position in Mesa Laboratories is 71,885,816 shares, and hedge funds decreased their holdings by 4.1K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology